Exelixis Inc Other Non-Current Liabilities
Exelixis Inc (EXEL) had Other Non-Current Liabilities of $122.62 million as of 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-07-03: Other Liabilities, Noncurrent $122.62M.
- 2026-04-03: Other Liabilities, Noncurrent $117.33M.
- 2026-01-02: Other Liabilities, Noncurrent $104.42M.
- 2025-10-03: Other Liabilities, Noncurrent $112.61M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-07-03 | $122.62M 10-Q · filed 2026-08-05 | |
| 2026-04-03 | $117.33M 10-Q · filed 2026-05-05 | |
| 2026-01-02 | $104.42M 10-Q · filed 2026-08-05 | |
| 2025-10-03 | $112.61M 10-Q · filed 2025-11-04 | |
| 2025-07-04 | $128.59M 10-Q · filed 2025-07-28 | |
| 2025-04-04 | $120.00M 10-Q · filed 2025-05-13 | |
| 2025-01-03 | $108.89M 10-K · filed 2026-02-10 | |
| 2024-09-27 | $96.07M 10-Q · filed 2024-10-29 | |
| 2024-06-28 | $109.67M 10-Q · filed 2024-08-06 | |
| 2024-03-29 | $101.27M 10-Q · filed 2024-04-30 | |
| 2023-12-29 | $94.22M 10-K · filed 2025-02-11 | |
| 2023-09-29 | $61.62M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $73.50M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $67.38M 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $68.53M 10-K · filed 2024-02-06 | $61.95M 10-K · filed 2023-02-07 |
| 2022-09-30 | $1.91M 10-Q · filed 2022-11-01 | |
| 2022-07-01 | $17.39M 10-Q · filed 2022-08-09 | |
| 2022-04-01 | $12.52M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $8.02M 10-K · filed 2023-02-07 | |
| 2021-10-01 | $4.09M 10-Q · filed 2021-11-02 | |
| 2021-07-02 | $7.07M 10-Q · filed 2021-08-05 | |
| 2021-04-02 | $3.42M 10-Q · filed 2021-05-06 | |
| 2021-01-01 | $721.00K 10-K · filed 2022-02-18 | |
| 2020-10-02 | $721.00K 10-Q · filed 2020-11-05 | |
| 2020-07-03 | $7.21M 10-Q · filed 2020-08-06 | |
| 2020-04-03 | $5.46M 10-Q · filed 2020-05-05 | |
| 2020-01-03 | $2.35M 10-K · filed 2021-02-11 | |
| 2019-09-27 | $975.00K 10-Q · filed 2019-10-30 | |
| 2019-06-28 | $4.50M 10-Q · filed 2019-07-31 | |
| 2019-03-29 | $3.36M 10-Q · filed 2019-05-01 | |
| 2018-12-28 | $1.29M 10-K · filed 2020-02-25 | |
| 2018-09-28 | $2.61M 10-Q · filed 2018-11-01 | |
| 2018-06-29 | $3.63M 10-Q · filed 2018-08-01 | |
| 2018-03-30 | $17.11M 10-Q · filed 2018-05-02 | |
| 2017-12-30 | $1.71M 10-Q · filed 2018-11-01 | |
| 2017-12-29 | $1.71M 10-K · filed 2019-02-22 | $16.64M 10-K · filed 2018-02-26 |
| 2017-09-30 | $16.01M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $16.69M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $3.71M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $541.00K 10-Q · filed 2017-11-01 | |
| 2016-12-30 | $541.00K 10-K · filed 2018-02-26 | |
| 2016-09-30 | $759.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.08M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $1.32M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $2.96M 10-K · filed 2017-02-27 | $1.57M 10-K · filed 2016-02-29 |
| 2015-09-30 | $1.88M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $2.35M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $2.96M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $4.17M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $4.77M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $5.10M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $5.47M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $4.67M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $5.73M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $5.88M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $6.11M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $6.26M 10-K · filed 2014-02-20 | |
| 2012-09-30 | $7.77M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $7.56M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $7.75M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $7.84M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $8.25M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $8.45M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $9.01M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |